Osiris Therapeutics: Biotech's Former Brass Fights SEC Efforts To Get Court Wins

Attorneys for the former CEO and CFO of biotechnology company Osiris Therapeutics Inc. on Monday tried to rebuff the U.S. Securities and Exchange Commission's efforts to secure partial judgments against them, claiming the agency was relying on thin evidence to prove the executives cooked the company's books.